Combining biodegradable lysine-based peptides with a cationic lipid created self-assembling nanoparticles that delivered genes into cells more efficiently than the lipid alone, without increasing toxicity.
Zeta potential >+20 mVSurface charge threshold above which the peptide-lipid nanoparticles achieved high gene transfection efficiency
What the researchers found
Self-assembled nanoparticles combining ε-oligo(L-lysine) peptides with the cationic lipid DOTAP and plasmid DNA achieved transfection efficiency that exceeded DOTAP alone, without a significant increase in cytotoxicity.
High transfection efficiency correlated with a zeta potential above +20 mV and a particle size below 500 nm. Synchrotron small-angle X-ray scattering confirmed the complexes formed ordered lamellar (layered) supramolecular structures, suggesting that the structural organization contributes to their gene-delivery performance.
Why it matters
Safe and effective gene delivery remains one of the biggest challenges in gene therapy. Viral vectors work well but carry safety risks. This study shows that simple, biodegradable peptides can be combined with lipids to create non-toxic nanoparticles that outperform the lipid alone — offering a modular, tunable platform for non-viral gene delivery.
How the study worked
The researchers synthesized ε-oligo(L-lysine) peptides via solid-phase synthesis, creating branched variants with arginine and histidine side chains. These peptides were combined with the cationic lipid DOTAP and plasmid DNA to form nanoparticles. The team measured particle size and surface charge (zeta potential), examined supramolecular structure using synchrotron small-angle X-ray scattering (SAXS), and tested gene delivery efficiency and cytotoxicity in HeLa cells in vitro.
What this study cannot tell us
The study was conducted entirely in vitro using HeLa cells, so it is unknown whether these nanoparticles would perform similarly in living organisms. The specific gene expression levels and how they compare to established commercial transfection agents were not detailed. Long-term stability and biodistribution of the nanoparticles were not assessed.
How to read the evidence
This is an in vitro laboratory study using a single cell line (HeLa). While it provides clear mechanistic and biophysical data, the findings have not been validated in animal models or clinical settings, limiting the evidence strength.
When this study was published
Published in 2012, this study is over a decade old. The fundamental principles of peptide-lipid self-assembly for gene delivery remain relevant and have been built upon in the development of modern lipid nanoparticle technologies.
The bigger picture
Non-viral gene delivery systems are a growing area of research as the field moves toward safer alternatives to viral vectors. This work contributes to the broader effort by demonstrating that rationally designed peptide-lipid combinations can self-assemble into well-organized nanoparticles with enhanced delivery properties, a principle now widely applied in lipid nanoparticle platforms including those used for mRNA vaccines.
Questions still open
- Do these peptide-lipid nanoparticles maintain their transfection efficiency and low toxicity in animal models?
- Can the peptide design be further optimized — for example by varying chain length or branching — to target specific cell types?
- How do these nanoparticles compare head-to-head with commercially available non-viral transfection reagents?
Common questions
What are ε-oligo(L-lysines) and why are they useful for gene delivery?
Why is combining peptides with lipids better than using lipids alone?
Read the original research
Biophysical properties and supramolecular structure of self-assembled liposome/ε-peptide/DNA nanoparticles: correlation with gene delivery.
Biomacromolecules, 13(1), 124-31
Citation
Yan, Jiang; Korolev, Nikolay; Eom, Khee Dong; Tam, James P; Nordenskiöld, Lars. (2012). Biophysical properties and supramolecular structure of self-assembled liposome/ε-peptide/DNA nanoparticles: correlation with gene delivery.. Biomacromolecules, 13(1), 124-31. https://doi.org/10.1021/bm201359r